KA-EX®, a Swiss health tech innovator, has secured $4.5 million in investment capital from investors. The funding round will support the company's mission to redefine recovery and performance through its clinically validated functional beverages and powders.
KA-EX, a winner of the 2025 World Food Innovation Award, combines science-backed functional efficacy with convenient, on-the-go delivery formats. Central to its innovation is the proprietary VICAP dual-chamber system, which enables the stabilization and delivery of chemically sensitive active ingredients previously unviable in liquid form. This technology sets a new standard for performance nutrition.
Trusted by thousands of professional athletes, KA-EX has become one of Switzerland’s leading dietary supplement brands. Its products are widely available across pharmacies, major retailers, gyms, convenience channels, vending machines, and online, with expansion into the U.S. market currently underway.
This $4.5 million funding round marks a significant milestone for KA-EX. The capital secured from investors will be instrumental in accelerating the company's strategic growth initiatives. KA-EX plans to deploy these funds to further its market expansion, particularly in the U.S., and to continue investing in research and development to enhance its portfolio of functional beverages and powders.
The investment underscores confidence in KA-EX's innovative approach to health and performance nutrition. With this new capital, the company is positioned to strengthen its leadership in the recovery and performance sector, aiming to broaden its reach and impact on a global scale.
